Perinatal SSRI exposure permanently alters cerebral serotonin receptor mRNA in mice but does not impact adult behaviors

References

• Bakker MK, Kolling P, van den Berg PB, et al. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol. 2008;65:600–606.
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63:898–906.
   PubMed Web of Science ®Google Scholar
• Olivier JD, Akerud H, Kaihola H, et al. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci. 2013;7:73.
   PubMed Web of Science ®Google Scholar
• Wichman CL, Fothergill A, Moore KM, et al. Recent trends in selective serotonin reuptake inhibitor use in pregnancy. J Clin Psychopharmacol. 2008;28:714–716.
   PubMed Web of Science ®Google Scholar
• Cooper WO, Willy ME, Pont SJ, et al. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007;196:544 e1–5.
   Web of Science ®Google Scholar
• Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci. 2003;4:1002–1012.
   PubMed Web of Science ®Google Scholar
• Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142:402–408.
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Eckstein Grunau R, Fitzgerald C, et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res. 2002;51:443–453.
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Gingrich JA, Ansorge MS. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009;86:672–677.
   PubMed Web of Science ®Google Scholar
• Hanley GE, Brain U, Oberlander TF. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res. 2015;78:174–180.
   PubMed Web of Science ®Google Scholar
• Croen LA, Grether JK, Yoshida CK, et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68:1104–1112.
   PubMed Web of Science ®Google Scholar
• Harrington RA, Lee LC, Crum RM, et al. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics. 2014;133:e1241–1248.
   PubMed Web of Science ®Google Scholar
• Gidaya NB, Lee BK, Burstyn I, et al. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord. 2014;44:2558–2567.
   PubMed Web of Science ®Google Scholar
• El Marroun H, White TJ, van der Knaap NJ, et al. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry. 2014;205:95–102.
   PubMed Web of Science ®Google Scholar
• Rai D, Lee BK, Dalman C, et al. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346:f2059.
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336:258–262.
   PubMed Web of Science ®Google Scholar
• Misri S, Reebye P, Kendrick K, et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163:1026–1032.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Palo P, et al. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther. 2003;73:330–337.
   PubMed Web of Science ®Google Scholar
• Maciag D, Simpson KL, Coppinger D, et al. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology. 2006;31:47–57.
   PubMed Web of Science ®Google Scholar
• Ansorge MS, Morelli E, Gingrich JA. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci. 2008;28:199–207.
   PubMed Web of Science ®Google Scholar
• Haskell SE, Hermann GM, Reinking BE, et al. Sertraline exposure leads to small left heart syndrome in adult mice. Pediatr Res. 2013;73:286–293.
   PubMed Web of Science ®Google Scholar
• Del’Guidice T, Lemay F, Lemasson M, et al. Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation. Neuropsychopharmacology. 2014;39:1125–1134.
   PubMed Web of Science ®Google Scholar
• Hendrick V, Stowe ZN, Altshuler LL, et al. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160:993–996.
   PubMed Web of Science ®Google Scholar
• Meyer LR, Zhu V, Miller A, et al. Growth restriction, leptin, and the programming of adult behavior in mice. Behav Brain Res. 2014;275:131–135.
   PubMed Web of Science ®Google Scholar
• Alwan S, Friedman JM. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs. 2009;23:493–509.
   PubMed Web of Science ®Google Scholar
• Sorensen MJ, Gronborg TK, Christensen J, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449–459.
   PubMedGoogle Scholar
• Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry. 2002;159:2055–2061.
   PubMed Web of Science ®Google Scholar
• Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;369:2406–2415.
   PubMed Web of Science ®Google Scholar
• Semple BD, Blomgren K, Gimlin K, et al. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol. 2013;106-107:1–16.
   PubMed Web of Science ®Google Scholar
• Wegerer V, Moll GH, Bagli M, et al. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J Child Adolesc Psychopharmacol. 1999;9:13–24. discussion 5-6.
   PubMed Web of Science ®Google Scholar
• Bouet V, Klomp A, Freret T, et al. Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology (Berl). 2012;221:329–339.
   PubMed Web of Science ®Google Scholar
• Thomas KL, Ellingrod VL. Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions. Pharmacotherapy. 2009;29:822–831.
   PubMed Web of Science ®Google Scholar
• Oblak A, Gibbs TT, Blatt GJ. Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism. Autism Res. 2013;6:571–583.
   PubMed Web of Science ®Google Scholar
• Pehrson AL, Jeyarajah T, Sanchez C. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission. CNS Spectrums. 2016;21:162–183.
   PubMed Web of Science ®Google Scholar
• Celada P, Puig MV, Artigas F. Serotonin modulation of cortical neurons and networks. Front Integr Neurosci. 2013;7:25.
   PubMedGoogle Scholar
• Altieri SC, Garcia-Garcia AL, Leonardo ED, et al. Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior. ACS Chem Neurosci. 2013;4:72–83.
   PubMed Web of Science ®Google Scholar
• Aznar S, Hervig Mel S. The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases. Neurosci Biobehav Rev. 2016;64:63–82.
   PubMed Web of Science ®Google Scholar
• Shishkina GT, Kalinina TS, Dygalo NN. Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect. Neuroscience. 2007;150:404–412.
   PubMed Web of Science ®Google Scholar
• Kummet GJ, Haskell SE, Hermann GM, et al. Neonatal SSRI exposure programs a hypermetabolic state in adult mice. J Nutr Metab. 2012;2012:431574.
   PubMedGoogle Scholar
• Beliveau V, Ganz M, Feng L, et al. High-Resolution in vivo atlas of the human brain’s serotonin system. J Neurosci. 2017;37:120–128.
   PubMed Web of Science ®Google Scholar